Arxis' IPO Clears the First Test for Defense-Industrial Listings

By Erik Aronesty

BLOOMFIELD, Conn., April 17, 2026 - Arxis did more than get a billion-dollar IPO out the door. The Arcline-backed maker of mission-critical electronic and mechanical components priced above the original share count, opened well through issue price, and gave public investors a clean read on demand for aerospace-and-defense industrial compounders.

The company sold 40.5 million Class A shares at $28 each, raising about $1.13 billion before the underwriters' option. That was an upsized deal from the 37.7 million shares initially marketed at $25 to $28. Arxis also granted the banks a 30-day option for another 6.075 million shares, which would add roughly $170 million of primary stock at the offer price.

The after-market signal was not subtle. Reuters reported that ARXS opened Thursday at $38, nearly 36% above the IPO price, and the stock was still trading above the deal price Friday afternoon. For an issuer asking investors to underwrite both an acquisition-built platform and a sponsor-controlled governance structure, that matters.

The book had visible help. Funds or accounts managed by Capital International Investors, Capital Research Global Investors, Janus Henderson Investors and T. Rowe Price Investment Management indicated interest in buying up to $400 million of shares at the IPO price. The indication was not binding, and those shares are not subject to the underwriters' lock-up, but the order gave the syndicate a firmer center than most new issues have before pricing.

Goldman Sachs, Morgan Stanley and Jefferies led the offering, with Citigroup and RBC also in the bookrunner group and a long tail of co-managers including Baird, Guggenheim, Wells Fargo, William Blair, Rothschild & Co, Wolfe | Nomura Alliance and Citizens Capital Markets. Nasdaq approved the listing on the Global Select Market under ARXS, and the final prospectus says delivery is expected on or about April 17.

Arxis is not being sold as a simple parts manufacturer. The company says it generated $1.591 billion of 2025 revenue, $46.0 million of net income and a 35.9% adjusted EBITDA margin. It operates two segments: Electronic Components, about 44% of 2025 revenue, and Mechanical Components, about 56%. The mix is useful in the IPO pitch because Arxis can point to defense, space and commercial aerospace demand while still showing exposure to medical technology and specialized industrial markets.

The quality claim rests on designed-in components rather than volume manufacturing. Arxis says roughly 90% of revenue comes from proprietary products, with more than 5,000 customers and more than 600 platforms served. Its top 10 customers accounted for 36% of 2025 revenue, and no single customer or platform contributed more than 7%. Defense and space represented about 47% of 2025 revenue, commercial aerospace about 23%, and the remaining 30% came from medical technology and other specialized industrials.

The balance sheet is the less elegant part of the story. Arxis estimates net IPO proceeds of about $1.057 billion, or about $1.220 billion if the option is exercised in full. About $746 million is earmarked to repay borrowings under its term loan credit facility, with the remainder for working capital and general corporate purposes. The filing shows total debt moving from $2.661 billion to $1.915 billion on an as-adjusted basis after the offering.

Public buyers also get limited say. Arcline-affiliated funds will hold the Class B and convertible common stock, representing 99.09% of voting power after the offering, or 99.00% if the option is exercised in full. Arxis will be a controlled company under Nasdaq rules and plans to rely on related governance exemptions.

That is the trade. Investors are paying for a scaled, high-margin component platform with strong aerospace and defense exposure, visible cornerstone demand and a top-tier syndicate. They are also accepting leverage, sponsor control and a business model that has used acquisitions to build scale. The debut says the market was willing to make that exchange this week. The harder test starts after the IPO pop, when Arxis has to show that its engineered-parts margin story can compound as a public company.